P Moreillon1. Show Affiliations » 1. Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Abstract
Entities: Chemical Disease
Mesh: See more » Amoxicillin/therapeutic useAmoxicillin-Potassium Clavulanate CombinationAnti-Bacterial Agents/therapeutic useBacterial ProteinsCarrier Proteins/metabolismClavulanic Acids/therapeutic useDrug Therapy, Combination/therapeutic useHexosyltransferasesMethicillin/therapeutic useMicrobial Sensitivity TestsMuramoylpentapeptide Carboxypeptidase/metabolismOxacillin/therapeutic usePenicillin-Binding ProteinsPenicillinase/metabolismPeptidyl TransferasesStaphylococcal Infections/drug therapybeta-Lactamase Inhibitors
Substances: See more » Anti-Bacterial AgentsBacterial ProteinsCarrier ProteinsClavulanic AcidsPenicillin-Binding Proteinsbeta-Lactamase InhibitorsAmoxicillin-Potassium Clavulanate CombinationAmoxicillinPeptidyl TransferasesHexosyltransferasesMuramoylpentapeptide CarboxypeptidasePenicillinaseMethicillinOxacillin
Year: 1995 PMID: 7782261 DOI: 10.1093/jac/35.3.435
Source DB: PubMed Journal: J Antimicrob Chemother ISSN: 0305-7453 Impact factor: 5.790